Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model

BACKGROUND: The prevalence of human infections with the zoonotic pathogen Campylobacter jejuni is rising worldwide. Therefore, the identification of compounds with potent anti-pathogenic and anti-inflammatory properties for future therapeutic and/or preventive application to combat campylobacteriosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi, Soraya, Schmidt, Anna-Maria, Escher, Ulrike, Kittler, Sophie, Kehrenberg, Corinna, Thunhorst, Elisa, Bereswill, Stefan, Heimesaat, Markus M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947993/
https://www.ncbi.nlm.nih.gov/pubmed/31921356
http://dx.doi.org/10.1186/s13099-019-0343-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947993/
https://www.ncbi.nlm.nih.gov/pubmed/31921356
http://dx.doi.org/10.1186/s13099-019-0343-4

Ejemplares similares